Dear colleagues, Please share and disseminate through your network. On behalf of all the organizers, I want to remind you that registration continues to be open for the EMBO Course on “Quantifying Astrocyte Physiology by Models from Genome to Circuits,” which will be held at the University of Padua in Padua, Italy, from April 10 to 11, 2025. Please refer to the course website for further information: https://sites.google.com/view/embo-satellite-meeting/home The course is a Satellite Event of the EMBO Meeting on “Astrocytes: From Molecules to Systems,” which will follow in nearby Venice a couple of days later (April 14–18, 2025). The EMBO Course “Quantifying Astrocyte Physiology by Models from Genome to Circuits” is a two-day intensive course aimed at teaching essential modeling approaches to harness astrocyte biology revolving around four main themes such as (i) astrocyte genomics, (ii) intracellular calcium signaling, (iii) tripartite synapses, (iv) neuron-astrocyte networks. The course is open to researchers of any level in the Academia and Industry. Registration Policy Attendance to the Course is limited to 50 participants due to limited seating. Registrants that are also planning to attend the EMBO Workshop “Astrocytes: From Molecules to Systems” should register through this latter’s website: https://meetings.embo.org/event/25-astrocytes People who will not be selected to attend the EMBO Workshop “Astrocytes: From Molecules to Systems” can still opt to attend the course by registering through the course website: https://sites.google.com/view/embo-satellite-meeting/home Thank you for considering the matter. Maurizio De Pitta ----- Maurizio DE PITTA Principal Investigator Neuron-Glia Interactions Lab (NGILab) Krembil Research Institute, 4KD-509 60 Leonard Ave, Toronto, ON M5T 0S8, CA +1.416.603.5800 ext. 3290 This e-mail may contain confidential and/or privileged information for the sole use of the intended recipient. Any review or distribution by anyone other than the person for whom it was originally intended is strictly prohibited. If you have received this e-mail in error, please contact the sender and delete all copies. Opinions, conclusions or other information contained in this e-mail may not be that of the organization. If you feel you have received an email from UHN of a commercial nature and would like to be removed from the sender's mailing list please do one of the following: (1) Follow any unsubscribe process the sender has included in their email (2) Where no unsubscribe process has been included, reply to the sender and type "unsubscribe" in the subject line. If you require additional information please go to our UHN Newsletters and Mailing Lists page. Please note that we are unable to automatically unsubscribe individuals from all UHN mailing lists. Patient Consent for Email: UHN patients may provide their consent to communicate with UHN about their care using email. All electronic communication carries some risk. Please visit the UHN website and search “Using email to Communicate with Your UHN Health Care Team” to learn about the risks of electronic communication and how to protect your privacy. You may withdraw your consent to receive emails from UHN at any time. Please contact your care provider, if you do not wish to receive emails from UHN.